Sarepta Therapeutics Inc (SRPT)
124.25
+7.13
(+6.09%)
USD |
NASDAQ |
Apr 24, 16:00
124.25
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Debt to Equity Ratio: 1.441 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.441 |
| September 30, 2023 | 1.618 |
| June 30, 2023 | 1.666 |
| March 31, 2023 | 1.732 |
| December 31, 2022 | 4.012 |
| September 30, 2022 | 3.581 |
| June 30, 2022 | 1.515 |
| March 31, 2022 | 1.282 |
| December 31, 2021 | 1.182 |
| September 30, 2021 | 2.332 |
| June 30, 2021 | 2.253 |
| March 31, 2021 | 2.038 |
| December 31, 2020 | 1.303 |
| September 30, 2020 | 0.7852 |
| June 30, 2020 | 0.6656 |
| March 31, 2020 | 0.6009 |
| December 31, 2019 | 0.8334 |
| September 30, 2019 | 0.4385 |
| June 30, 2019 | 0.3922 |
| March 31, 2019 | 0.3157 |
| December 31, 2018 | 0.4074 |
| September 30, 2018 | 0.6493 |
| June 30, 2018 | 0.6286 |
| March 31, 2018 | 0.5546 |
| December 31, 2017 | 0.5462 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0449 |
| June 30, 2017 | 0.0297 |
| March 31, 2017 | 0.0319 |
| December 31, 2016 | 0.048 |
| September 30, 2016 | 0.0455 |
| June 30, 2016 | 0.1664 |
| March 31, 2016 | 0.151 |
| December 31, 2015 | 0.1229 |
| September 30, 2015 | 0.189 |
| June 30, 2015 | 0.1552 |
| March 31, 2015 | 0.0318 |
| December 31, 2014 | 0.0256 |
| September 30, 2014 | 0.0219 |
| June 30, 2014 | 0.0054 |
| March 31, 2014 | 0.0072 |
| December 31, 2013 | 0.0067 |
| September 30, 2013 | 0.0068 |
| June 30, 2013 | 0.0193 |
| March 31, 2013 | 0.0199 |
| December 31, 2012 | 0.0142 |
| September 30, 2012 | -0.3894 |
| June 30, 2012 | 0.08 |
| March 31, 2012 | 0.1299 |
| December 31, 2011 | 0.0594 |
| September 30, 2011 | 0.0586 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3922
Minimum
Jun 2019
4.012
Maximum
Dec 2022
1.562
Average
1.441
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| PTC Therapeutics Inc | -2.563 |
| Vertex Pharmaceuticals Inc | 0.00 |
| Regenxbio Inc | 0.00 |
| CytomX Therapeutics Inc | 0.00 |
| Apellis Pharmaceuticals Inc | 0.4783 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.265B |
| Total Liabilities (Quarterly) | 2.405B |
| Shareholders Equity (Quarterly) | 859.34M |
| Current Ratio | 3.946 |
| Net Debt Paydown Yield | 0.67% |